Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
Reversal of T-cell unresponsiveness by T-cell-conditioned medium in retrovirus MAV-2-O-induced immunosuppression in chickens.
Cancer Res. 1985 Oct;45(10):4871-5. Unique Identifier : AIDSLINE MED/85282211 Boni-Schnetzler M; Boni J; Franklin RM
Abstract:
Polyclonal activation of T-cells with concanavalin A has been used as an in vitro test system to study immunosuppression induced by the avian retrovirus MAV-2-O. The mitogenic responsiveness of peripheral blood lymphocytes from infected chickens was only weakly suppressed, that of spleen lymphocytes was highly suppressed. Addition of conditioned media rich in T-cell growth factor (TCGF) activity to cultures of infected birds resulted in a reconstitution of the suppressed mitogenic responsiveness up to the level found in lymphocyte cultures from normal chickens. This indicates that the defect of the observed immunopathology is not at the level of responding T-cells. Measurements of TCGF production always showed reduced TCGF levels in the suppressed cultures suggesting that there is a defect at the TCGF production level. This is further supported by the failure to reconstitute the suppressed mitogenic response with normal macrophages, which are involved in activation of TCGF producer T-cells.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY Animal Avian Leukosis/*IMMUNOLOGY Chickens Culture Media Human *Immune Tolerance Interleukin-2/ANALYSIS/BIOSYNTHESIS Lymphocyte Transformation Lymphocytes/ANALYSIS Macrophages/IMMUNOLOGY Spleen/ANALYSIS Support, Non-U.S. Gov't T-Lymphocytes/*IMMUNOLOGY JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.